Follow
Ahmed Elzoghby
Ahmed Elzoghby
Instructor of Medicine, Harvard Medical School, Brigham & Women's Hospital, Engineering in Medicine
Verified email at bwh.harvard.edu - Homepage
Title
Cited by
Cited by
Year
Albumin-based nanoparticles as potential controlled release drug delivery systems
AO Elzoghby, WM Samy, NA Elgindy
Journal of controlled release 157 (2), 168-182, 2012
15952012
Protein-based nanocarriers as promising drug and gene delivery systems
AO Elzoghby, WM Samy, NA Elgindy
Journal of controlled release 161 (1), 38-49, 2012
8802012
Gelatin-based nanoparticles as drug and gene delivery systems: Reviewing three decades of research
AO Elzoghby
Journal of Controlled Release 172 (3), 1075-1091, 2013
7112013
Casein-based formulations as promising controlled release drug delivery systems
AO Elzoghby, WSA El-Fotoh, NA Elgindy
Journal of controlled release 153 (3), 206-216, 2011
5192011
Inhalable particulate drug delivery systems for lung cancer therapy: Nanoparticles, microparticles, nanocomposites and nanoaggregates
HM Abdelaziz, M Gaber, MM Abd-Elwakil, MT Mabrouk, MM Elgohary, ...
Journal of Controlled Release 269, 374-392, 2018
3162018
Implications of protein-and peptide-based nanoparticles as potential vehicles for anticancer drugs
AO Elzoghby, MM Elgohary, NM Kamel
Advances in protein chemistry and structural biology 98, 169-221, 2015
1842015
Hybrid protein-inorganic nanoparticles: from tumor-targeted drug delivery to cancer imaging
AO Elzoghby, AL Hemasa, MS Freag
Journal of Controlled Release 243, 303-322, 2016
1512016
Self-assembled amphiphilic zein-lactoferrin micelles for tumor targeted co-delivery of rapamycin and wogonin to breast cancer
SA Sabra, AO Elzoghby, SA Sheweita, M Haroun, MW Helmy, ...
European Journal of Pharmaceutics and Biopharmaceutics 128, 156-169, 2018
1362018
Lactoferrin, a multi-functional glycoprotein: Active therapeutic, drug nanocarrier & targeting ligand
AO Elzoghby, MA Abdelmoneem, IA Hassanin, MM Abd Elwakil, ...
Biomaterials 263, 120355, 2020
1292020
Novel ionically crosslinked casein nanoparticles for flutamide delivery: formulation, characterization, and in vivo pharmacokinetics
AO Elzoghby, MW Helmy, WM Samy, NA Elgindy
International journal of nanomedicine, 1721-1732, 2013
1112013
Novel spray-dried genipin-crosslinked casein nanoparticles for prolonged release of alfuzosin hydrochloride
AO Elzoghby, WM Samy, NA Elgindy
Pharmaceutical research 30, 512-522, 2013
1092013
Protein-lipid nanohybrids as emerging platforms for drug and gene delivery: challenges and outcomes
M Gaber, W Medhat, M Hany, N Saher, JY Fang, A Elzoghby
Journal of Controlled Release 254, 75-91, 2017
1052017
Natural polymeric nanoparticles for brain-targeting: implications on drug and gene delivery
A O Elzoghby, M M Abd-Elwakil, K Abd-Elsalam, M T Elsayed, Y Hashem, ...
Current pharmaceutical design 22 (22), 3305-3323, 2016
1022016
Spray-dried casein-based micelles as a vehicle for solubilization and controlled delivery of flutamide: Formulation, characterization, and in vivo pharmacokinetics
AO Elzoghby, MW Helmy, WM Samy, NA Elgindy
European Journal of Pharmaceutics and Biopharmaceutics 84 (3), 487-496, 2013
932013
Albumin-based nanoparticles: A promising strategy to overcome cancer drug resistance
I Hassanin, A Elzoghby
Cancer Drug Resistance 3 (4), 930, 2020
892020
Shell-crosslinked zein nanocapsules for oral codelivery of exemestane and resveratrol in breast cancer therapy
AO Elzoghby, SA El-Lakany, MW Helmy, MM Abu-Serie, NA Elgindy
Nanomedicine 12 (24), 2785-2805, 2017
832017
Synthesis of lactoferrin mesoporous silica nanoparticles for pemetrexed/ellagic acid synergistic breast cancer therapy
OM Ali, AA Bekhit, SN Khattab, MW Helmy, YS Abdel-Ghany, M Teleb, ...
Colloids and Surfaces B: Biointerfaces 188, 110824, 2020
822020
Hyaluronate/lactoferrin layer-by-layer-coated lipid nanocarriers for targeted co-delivery of rapamycin and berberine to lung carcinoma
DM Kabary, MW Helmy, KA Elkhodairy, JY Fang, AO Elzoghby
Colloids and Surfaces B: Biointerfaces 169, 183-194, 2018
772018
Inhalable lactoferrin–chondroitin nanocomposites for combined delivery of doxorubicin and ellagic acid to lung carcinoma
MM Abd Elwakil, MT Mabrouk, MW Helmy, EZA Abdelfattah, SK Khiste, ...
Nanomedicine 13 (16), 2015-2035, 2018
762018
Zein-based nanocarriers as potential natural alternatives for drug and gene delivery: focus on cancer therapy
A Elzoghby, M Freag, H Mamdouh, K Elkhodairy
Current pharmaceutical design 23 (35), 5261-5271, 2017
762017
The system can't perform the operation now. Try again later.
Articles 1–20